Jul 15, 2026 07:36AM
Jul 15, 2026 07:23AM
Jul 15, 2026 07:22AM
Jul 14, 2026 04:53PM
Jul 14, 2026 04:53PM
Jun 3, 2026 10:13PM
Jun 3, 2026 10:13PM Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
Jun 3, 2026 07:19AM
Jun 3, 2026 07:19AM
Jun 2, 2026 08:26AM
Jun 2, 2026 08:25AM
Jun 2, 2026 08:11AM
May 18, 2026 07:05AM
May 14, 2026 04:01PM Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 1, 2026 05:03PM
May 1, 2026 05:03PM
Mar 25, 2026 04:01PM
Mar 9, 2026 05:42PM
Mar 9, 2026 05:42PM Celcuity Announces Publication of Results from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Study of Gedatolisib Regimens in HR+/HER2- Advanced Breast Cancer in Journal of Clinical Oncology
Feb 12, 2026 04:05PM
Feb 12, 2026 04:05PM
Jan 20, 2026 07:30AM
Jan 20, 2026 07:30AM
Jan 8, 2026 12:08PM
Dec 11, 2025 02:35PM
Dec 11, 2025 02:35PM Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
Nov 17, 2025 04:05PM
Nov 12, 2025 04:01PM
Oct 18, 2025 04:30AM
Oct 18, 2025 04:30AM
Sep 9, 2025 04:01PM
Sep 9, 2025 04:01PM
Aug 27, 2025 04:05PM Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
Aug 18, 2025 06:47AM
Aug 14, 2025 04:01PM
Jul 28, 2025 07:00AM
Jul 28, 2025 07:00AM
Dec 11, 2024 07:05AM
Dec 11, 2024 07:05AM
May 30, 2024 02:29PM Stifel Reiterates Buy Rating on Celcuity Inc (CELC)
May 30, 2024 07:05AM
May 30, 2024 07:00AM
Nov 13, 2023 07:05AM
Aug 22, 2023 04:01PM
Mar 23, 2023 04:00PM
Dec 7, 2022 04:00PM
Nov 10, 2022 04:00PM Celcuity Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Aug 11, 2022 04:00PM

326,362 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All